查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564102

全球心血管植入市场

Cardiovascular Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球心血管植入市场预计将达到435亿美元

2023年全球心血管植入市场估计为311亿美元，预计2030年将达到435亿美元，2023-2030年分析期间复合年增长率为4.9%。支架是本报告分析的细分市场之一，预计复合年增长率为 5.5%，到分析期结束时将达到 187 亿美元。分析期间 ICD 细分市场的复合年增长率预计为 3.9%。

美国市场预估成长85亿美元，中国复合年增长率4.5%

预计 2023 年美国心血管植入市场规模将达 85 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达68亿美元，2023-2030年分析期间复合年增长率为4.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.8% 和 3.7%。在欧洲，德国的复合年增长率预计为 3.9%。

全球心血管植入市场—主要趋势与驱动因素总结

心血管植入如何改变心臟疾病的治疗？

心血管植入是一种专门的医疗设备，旨在透过支持或替换受损的心血管结构来治疗和管理各种与心臟相关的疾病。这些设备包括调节异常心律（心律不整）的心律调节器、保持动脉开放以维持正常血流的支架以及用于更换心臟中患病或故障的瓣膜的心臟瓣膜。其他重要的心血管植入类型包括植入式心臟整流去颤器(ICD)，用于监测和纠正危及生命的心律不整；以及辅助人工心臟(VAD)，用于帮助衰弱的心臟将血液泵送到全身。心血管植入的重要性源自于它们能够解决一些最严重且危及生命的心臟疾病。例如，心律调节器和 ICD 用于治疗心律不整（心臟跳动过快、过慢或不规则）的患者，以帮助预防心臟麻痹。支架可以挽救患有冠状动脉疾病的患者的生命，冠状动脉疾病会导致冠状动脉阻塞并导致心臟病发作。支架保持动脉畅通，确保血液持续流向心肌并防止严重併发症。同样，心臟瓣膜植入用于取代狭窄（狭窄）或渗漏（逆流）的瓣膜（无论是机械瓣膜还是生物瓣膜），并帮助心臟维持有效的血液循环。随着心臟衰竭、冠状动脉疾病和瓣膜性心臟病等心臟病变得越来越普遍，心血管植入正在成为那些生活品质严重受限甚至过早死亡的患者最有效和可靠的治疗选择。其中之一。透过恢復正常的心臟功能或支持故障的心臟，这些植入可以显着减轻呼吸急促、胸痛和疲劳等症状，帮助患者恢復日常生活。

科技如何改善心血管植入？

技术进步大大提高了心血管植入的有效性、安全性和耐用性，使其更加可靠并可供更多患者使用。最重要的创新之一是开发更小、侵入性较小的设备。例如，现代心律心律调节器比以前的心律调节器小得多，并且无需进行侵入性手术即可植入，从而大大缩短了恢復时间和併发症的风险。同样，药物释放型支架不仅可以物理支撑血管，还可以释放药物以防止动脉随着时间的推移再次狭窄。在心臟瓣膜置换术领域，经导管瓣膜植入已成为传统心臟直视手术的微创替代方案，使高风险患者能够接受挽救生命的移植手术，而无需承担大手术带来的风险。此外，生物相容性材料的进步使植入更耐用、与人体更融合，减少了排斥反应的机会并改善了长期结果。穿戴式科技和远端监测系统现已与许多植入整合，使医疗保健提供者能够即时监测患者的心臟功能，并在必要时远端调整治疗计划。这样可以在出现问题时早期疗育，从而显着改善患者照护。此外，人工智慧和机器学习越来越多地融入这些设备中，透过分析患者资料并在异常导致严重健康事件之前检测异常，提供了预测和预防併发症的潜力。此类创新正在重塑心血管治疗领域，使植入比以往更安全、更有效、对患者更友善。

哪些趋势正在塑造心血管植入市场？

几个关键趋势正在推动心血管植入市场的成长和开拓，这反映了医疗技术的进步、患者人口结构的变化以及医疗保健实践的不断发展。最重要的趋势之一是对微创手术的需求不断增长。随着越来越多的患者和医疗保健提供者寻求侵入性较小的选择，以避免与传统手术相关的併发症和恢復时间，可以透过导管或小切口进行治疗的心血管植入越来越受欢迎。这种趋势在经导管主动脉瓣置换术(TAVR) 的使用不断增加中尤其明显。 TAVR 让严重主动脉瓣狭窄患者无需进行心臟直视手术即可接受挽救生命的瓣膜植入术。影响市场的另一个主要趋势是，由于人口老化以及肥胖、糖尿病和高血压等文明病的增加，心血管疾病的盛行率不断增加。随着心臟病患者数量的不断增加，对治疗这些疾病的心血管植入的需求也不断增加。这一需求也受到病患监测和资料分析的进步的推动，这些进步使得治疗更加个人化和主动。允许临床医生即时追踪植入性能的远端监控技术变得越来越普遍，从而可以在必要时进行快速调整和介入。将人工智慧和机器学习融入植入设备的趋势也产生了重大影响。这些技术使设备更加智慧、更有高效，使其能够适应不断变化的患者状况、预测潜在问题并即时优化治疗。此外，人们对开发生物分解性的支架和其他临时心血管植入越来越感兴趣，这些植入物在发挥其功能后会自发性溶解，从而可以减少进一步手术干预的需要。随着这些趋势的不断发展，心血管植入在治疗各种心臟病方面的能力和用途将进一步扩大。

推动心血管植入市场成长的因素有哪些？

心血管植入市场的成长受到技术进步、人口变化和不断变化的医疗保健趋势等多个因素的推动。最突出的驱动因素之一是全球心血管疾病盛行率不断上升，特别是随着人口老化以及更多患者患有糖尿病、高血压和肥胖等危险因子。随着越来越多的患者需要长期治疗心臟疾病，对心律调节器、支架和人工瓣膜等心血管植入的需求不断增加。技术创新也是一个主要的成长要素。微创植入治疗（例如经导管瓣膜置换术和无导线心律调节器）的发展扩大了适合这些治疗的患者范围，特别是无法接受传统手术的高风险患者。另一个重要的驱动因素是将远端监控和人工智慧整合到可植入设备中。这些进步实现了即时资料追踪和预测分析，使医疗保健提供者能够持续监测患者状况并及时调整治疗计划。透过这种积极主动的方法来管理心臟疾病可以改善患者的治疗效果，并减少紧急介入和再入院的需要。此外，对患者客製化治疗计划和个人化医疗的日益关注正在导致针对个别患者需求的植入市场的开拓，进一步推动市场成长。旨在改善先进医疗技术取得的监管核准和政府措施也有助于心血管植入市场的扩张。在北美和欧洲等地区，简化的监管流程正在加速将新型尖端植入引入诊所。此外，新兴市场医疗保健支出的增加正在改善先进心血管治疗的可近性，并推动植入在这些地区的采用。最后，向基于价值的医疗保健的转变强调患者的长期治疗结果而不是短期治疗，这鼓励使用耐用且可靠的心血管植入，进一步促进市场成长。

受访企业范例（29家知名企业）

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10903

Global Cardiovascular Implants Market to Reach US$43.5 Billion by 2030

The global market for Cardiovascular Implants estimated at US$31.1 Billion in the year 2023, is expected to reach US$43.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stents, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$18.7 Billion by the end of the analysis period. Growth in the ICD segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.5 Billion While China is Forecast to Grow at 4.5% CAGR

The Cardiovascular Implants market in the U.S. is estimated at US$8.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Cardiovascular Implants Market - Key Trends and Drivers Summarized

How Are Cardiovascular Implants Transforming the Treatment of Heart Conditions?

Cardiovascular implants are specialized medical devices designed to treat and manage a wide range of heart-related conditions by either supporting or replacing damaged cardiovascular structures. These devices include a variety of tools such as pacemakers, which help regulate abnormal heart rhythms (arrhythmias), stents that keep arteries open to maintain proper blood flow, and heart valves that replace diseased or malfunctioning valves within the heart. Other important types of cardiovascular implants include implantable cardioverter defibrillators (ICDs), which monitor and correct life-threatening irregular heartbeats, and ventricular assist devices (VADs), which help a weakened heart pump blood throughout the body. The critical importance of cardiovascular implants stems from their ability to address some of the most severe and life-threatening heart conditions. For example, pacemakers and ICDs are used in patients suffering from arrhythmias, where the heart beats too fast, too slow, or irregularly, and can help prevent sudden cardiac arrest. Stents are lifesaving in cases of coronary artery disease, where blocked arteries can lead to heart attacks. By keeping these arteries open, stents ensure continuous blood flow to the heart muscle, preventing severe complications. Similarly, heart valve implants, whether mechanical or biological, are used to replace valves that are either narrowed (stenosis) or leaky (regurgitation), helping the heart to maintain efficient blood circulation. As heart conditions like heart failure, coronary artery disease, and valve disorders become more prevalent, cardiovascular implants have emerged as one of the most effective and reliable treatment options for patients who would otherwise face severe limitations in quality of life, or even premature death. By restoring normal heart function or supporting a failing heart, these implants help patients return to their daily activities with a significant reduction in symptoms like shortness of breath, chest pain, or fatigue.

How Has Technology Enhanced Cardiovascular Implants?

Technological advancements have greatly enhanced the effectiveness, safety, and durability of cardiovascular implants, making them more reliable and accessible for a broader range of patients. One of the most significant innovations has been the development of miniaturized, less invasive devices. For example, modern pacemakers are much smaller than their predecessors and can now be implanted without the need for invasive surgery, significantly reducing recovery times and the risk of complications. Similarly, drug-eluting stents have been developed to not only physically support blood vessels but also release medication to prevent the re-narrowing of arteries over time. In the field of heart valve replacement, transcatheter valve implantation has emerged as a minimally invasive alternative to traditional open-heart surgery, allowing high-risk patients to receive life-saving implants without the risks associated with major surgery. Additionally, advancements in biocompatible materials have made implants more durable and better integrated with the human body, reducing the chances of rejection and improving long-term outcomes. Wearable technology and remote monitoring systems are now integrated with many implants, allowing healthcare providers to monitor a patient's heart function in real time and adjust treatment plans remotely if necessary. This has significantly improved patient care by enabling early intervention when problems arise. Furthermore, artificial intelligence and machine learning are being incorporated into these devices, offering the potential to predict and prevent complications by analyzing patient data and detecting irregularities before they lead to serious health events. These innovations are reshaping the landscape of cardiovascular care, making implants safer, more effective, and more patient-friendly than ever before.

What Trends Are Shaping the Cardiovascular Implants Market?

Several key trends are driving the growth and development of the cardiovascular implants market, reflecting advancements in medical technology, changing patient demographics, and evolving healthcare practices. One of the most important trends is the increasing demand for minimally invasive procedures. As more patients and healthcare providers seek less invasive options to avoid the complications and recovery time associated with traditional surgeries, cardiovascular implants that can be delivered via catheters or small incisions are becoming more popular. This trend is particularly evident in the rising use of transcatheter aortic valve replacement (TAVR) procedures, which allow patients with severe aortic stenosis to receive life-saving valve implants without open-heart surgery. Another major trend shaping the market is the growing prevalence of cardiovascular diseases, driven by aging populations and the rise in lifestyle-related conditions such as obesity, diabetes, and hypertension. As the number of patients with heart disease continues to rise, so does the need for cardiovascular implants to treat these conditions. This demand is also fueled by advancements in patient monitoring and data analytics, which enable more personalized and proactive care. Remote monitoring technologies that allow clinicians to track the performance of implants in real-time are becoming increasingly common, allowing for quicker adjustments and interventions if necessary. The trend towards integrating AI and machine learning into implantable devices is also having a profound impact. These technologies allow devices to adapt to changing patient conditions, predict potential problems, and optimize therapy in real-time, making them smarter and more efficient. Moreover, there is growing interest in developing biodegradable stents and other temporary cardiovascular implants that can perform their function and then naturally dissolve, reducing the need for further surgical interventions. As these trends continue to evolve, they are likely to further expand the capabilities and applications of cardiovascular implants in treating a wide range of heart conditions.

What Factors Are Driving the Growth of the Cardiovascular Implants Market?

The growth in the cardiovascular implants market is driven by several factors linked to technological advancements, demographic shifts, and evolving healthcare trends. One of the most prominent drivers is the rising incidence of cardiovascular diseases globally, particularly in aging populations and among individuals with risk factors such as diabetes, hypertension, and obesity. As more patients require long-term management of heart conditions, the demand for cardiovascular implants, such as pacemakers, stents, and artificial valves, continues to rise. Technological innovations have also been a key growth driver. The development of minimally invasive implant procedures, such as transcatheter valve replacements and leadless pacemakers, has broadened the patient pool eligible for these treatments, particularly among high-risk individuals who cannot undergo traditional surgery. Another significant driver is the integration of remote monitoring and AI into implantable devices. These advancements allow for real-time data tracking and predictive analytics, enabling healthcare providers to monitor a patient’s condition continuously and make timely adjustments to treatment plans. This proactive approach to managing heart conditions improves patient outcomes and reduces the need for emergency interventions or hospital readmissions. Additionally, the increased focus on patient-specific treatment plans and personalized medicine has led to the development of implants tailored to individual patient needs, further boosting market growth. Regulatory approvals and government initiatives aimed at improving access to advanced medical technologies have also contributed to the expansion of the cardiovascular implants market. In regions such as North America and Europe, streamlined regulatory processes have accelerated the introduction of new, cutting-edge implants into clinical practice. Furthermore, increasing healthcare expenditure in emerging markets has improved access to advanced cardiovascular care, driving the adoption of implants in these regions. Finally, the shift towards value-based healthcare, where the focus is on long-term patient outcomes rather than short-term treatments, has incentivized the use of durable and reliable cardiovascular implants, further propelling market growth.

Select Competitors (Total 29 Featured) -

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiovascular Implants - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cardiovascular Diseases Spurs Demand for Cardiovascular Implants
    • Advancements in Biocompatible Materials Strengthen the Business Case for Next-Generation Implants
    • Aging Population and Increasing Incidence of Heart Failure Propel Growth of Cardiovascular Implants Market
    • Shift Toward Minimally Invasive Procedures Expands Addressable Market for Advanced Cardiovascular Implants
    • Here's How Wearable Technology and Remote Monitoring Capabilities Drive Adoption of Smart Cardiovascular Implants
    • Growing Adoption of Transcatheter Implant Procedures Spurs Demand for Innovative Cardiovascular Solutions
    • Post-Surgical Monitoring Capabilities Boost Demand for Intelligent Cardiovascular Implants
    • Growing Use of 3D Printing Technology in Cardiovascular Implants Propels Innovation and Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiovascular Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Heart Valve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Implanted Cardiac Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CRT Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030

IV. COMPETITION